Contract analysis

I. Purpose and Executive Summary The purpose of this memorandum is to provide a comprehensive status update on the declaratory judgment action captioned Whitmore Aerospace LLC v. Hargrove-Dalton Defense Systems, Inc., No. 1:22-cv-10147-RMB (S.D.N.Y.), and all related workstreams as of mid-March 2025. This memorandum also sets forth recommended next steps for client decision-making across the litigation, administrativ

1. DCMA Administrative Review Monitoring. Continue regular coordination with Ashford & Reeves LLP (Harold Reeves, Natalie Cheng) to monitor the COFD timeline, and request that Ashford & Reeves make a formal inquiry to ACO Lt. Col. Vickers regarding the anticipated timeline for issuance of the COFD.

2. Insurance Coverage Follow-Up. Send a renewed written demand to Meridian Surety & Insurance Group (Rachel Underwood, Senior Claims Counsel) pressing for a definitive coverage determination. If a denial is received, perform a cost-benefit analysis of a potential coverage action.

3. Contingency Planning for Litigation Reactivation. Finalize the contingency reactivation plan outlined in Patrick Gallagher's February 20, 2025 memorandum, including identification and preliminary vetting of expert witnesses, preparation of a draft motion to lift the stay, and preparation of a refreshed litigation budget for post-reactivation phases.

4. Settlement Posture Assessment. Defer formal settlement overtures until after the COFD issues, at which point the factual predicate will be clarified and WAL's leverage can be more precisely assessed. Reassess settlement posture promptly once the COFD is in hand. Each of these recommendations is discussed in detail below.

II. Case Identification and Procedural Background A. Case Caption and Court The case is captioned Whitmore Aerospace LLC v. Hargrove-Dalton Defense Systems, Inc., No. 1:22-cv-10147-RMB, and is pending in the United States District Court for the Southern District of New York. The matter is assigned to the Honorable Richard M. Brannigan, United States District Judge, with the Honorable Allison P. Kurtz, United States M

III. Current Status of the Stayed Litigation A. The Stay Order The stay was entered on March 17, 2023, by Judge Brannigan pursuant to the parties' Joint Stipulation to Stay. The order provides that all proceedings in the case — including discovery, motion practice, and all scheduling deadlines — are tolled during the pendency of the stay. The sole ongoing obligation imposed by the court is the requirement that the pa

IV. Status of the DCMA Administrative Review A. Background on the Administrative Process The DCMA Contracting Officer's Preliminary Determination ("COPD") was issued on August 1, 2022, by ACO Lt. Col. Sandra M. Vickers, DCMA Northern Virginia. The COPD identified $14,726,583 in cost overruns on the ATAP program. The procuring contracting agency is the U.S. Air Force, Air Force Life Cycle Management Center ("AFLCMC"),

V. Insurance Coverage Status A. Policies at Issue Two insurance policies issued by Meridian Surety & Insurance Group are potentially implicated by the HDDS indemnification demand: (1) Directors & Officers Liability Policy. Policy No. MSI-DO-2022-07814; $10,000,000 aggregate limit; $250,000 retention. The current policy period is July 1, 2024 – July 1, 2025 (renewed annually). The D&O policy provides coverage for loss

VI. Credit Facility Compliance A. Facility Terms and Notification History WAL maintains a $75,000,000 senior secured revolving credit facility pursuant to a Credit Agreement dated March 15, 2021, with Ridgeline National Bank, N.A. ("Ridgeline") as administrative agent. The lending syndicate includes Ridgeline and two additional lender participants. The facility is secured by substantially all of WAL's assets, includi

Section 6.07(b) of the Credit Agreement requires WAL to provide written notice to the administrative agent of any litigation, proceeding, or claim against WAL that involves an amount in controversy exceeding $5,000,000, within 15 business days of WAL's becoming aware of such litigation, proceeding, or claim. WAL complied with this notification requirement in a timely manner. An initial notice was delivered to David K

VII. Financial Statement Treatment Pinnacle Advisory Partners LLC, WAL's independent auditor, completed its audit of WAL's fiscal year 2022 financial statements on April 14, 2023. The engagement partner is Thomas Brennan, CPA. As part of the FY 2022 audit, Pinnacle performed an analysis of the HDDS indemnification claim under Accounting Standards Codification ("ASC") 450, Contingencies. Pinnacle's ASC 450 analysis co

VIII. Fees and Budget Summary A. Engagement Terms Calderwood & Harkness was retained by WAL pursuant to an engagement letter dated November 1, 2022. The engagement provides for representation on an hourly basis at the following rates: The original estimated budget for the matter through trial, prepared at the time of engagement, was $1,800,000 to $2,400,000. This estimate assumed a conventional litigation timeline of

IX. WAL's Substantive Legal Position — Summary Assessment A. Core Defenses WAL's substantive legal position rests on three core defenses, each of which is summarized below. A more detailed analysis is contained in the litigation strategy memorandum prepared at the time of filing and updated periodically thereafter; this section provides a summary-level assessment for purposes of the current status review.

1. Causation Under Section 11.4(b) The centerpiece of WAL's defense is the causation requirement in Section 11.4(b) of the Teaming Agreement. Section 11.4(b) provides, in pertinent part, that the Team Member (WAL) shall indemnify the Team Lead (HDDS) for any cost disallowances "caused by Team Member's acts or omissions in the performance of the work assigned to Team Member under this Agreement." WAL's position is tha

2. Overbreadth of Demand HDDS's indemnification demand encompasses the full $14,726,583 COPD amount, including $1,909,142 (12.97%) in cost overruns attributable to work packages other than WP-4. WAL performed work exclusively under WP-4 (titanium structural assemblies) pursuant to the Teaming Agreement. The non-WP-4 overruns relate to work packages performed by HDDS itself or by other subcontractors. There is no basi

3. Prematurity WAL also contends that the indemnification obligation under Section 11.4(b) has not been triggered because the COPD is a preliminary determination, not a final government action. Section 11.4(b) refers to indemnification for costs that are the subject of a "claim by the U.S. Government that costs … are unallowable, unreasonable, or otherwise subject to disallowance." WAL's position is that the COPD — a

X. Settlement Considerations The question of settlement posture was last addressed in Priya Anand's email analysis dated August 8, 2024, which recommended deferral of any formal settlement overtures until after issuance of the COFD. That recommendation remains in effect and is, in our judgment, the correct strategic course for the following reasons: First, the COFD will clarify the factual predicate underlying the pa

XI. Recommended Next Steps Based on the foregoing analysis, we recommend the following next steps for client consideration and approval: A. DCMA Administrative Review Monitoring

1. Continue Regular Coordination with Ashford & Reeves LLP. Calderwood & Harkness will continue its regular coordination protocol with Ashford & Reeves (Harold Reeves, Natalie Cheng) to monitor the COFD timeline and DCMA developments. Periodic coordination calls should continue on approximately a monthly basis, with supplemental calls as warranted by developments.

2. Formal Inquiry to ACO Lt. Col. Vickers. We recommend that Ashford & Reeves be directed to make a formal written inquiry to ACO Lt. Col. Sandra M. Vickers, DCMA Northern Virginia, regarding the anticipated timeline for completion of the headquarters legal review and issuance of the COFD. While there is no mechanism to compel the ACO to provide a timeline, a formal inquiry will demonstrate WAL's continued engagement

3. Seventh Joint Status Report. Calderwood & Harkness will prepare and file the seventh joint status report in coordination with Voss, Trager & Kendall LLP, on or about July 2025 (120 days from the filing of the Sixth Joint Status Report on March 6, 2025). B. Insurance Follow-Up

1. Renewed Written Demand to Meridian. Calderwood & Harkness will prepare and send a renewed written demand to Meridian Surety & Insurance Group (Rachel Underwood, Senior Claims Counsel) pressing for a definitive coverage determination. The letter will note the prolonged pendency of the reservation of rights (now exceeding two years and four months), invoke WAL's rights under New York Insurance Law and the implied co

2. Coverage Action Cost-Benefit Analysis. If Meridian issues a formal denial of coverage, Calderwood & Harkness will prepare a cost-benefit analysis of a potential coverage action, evaluating the likelihood of success on the coverage issues, the potential recovery, the cost of prosecution, and the strategic implications of concurrent litigation.

3. Policy Renewal Monitoring. WAL should ensure that annual policy renewals for both the D&O policy (Policy No. MSI-DO-2022-07814) and the CGL policy (Policy No. MSI-CGL-2021-33291) are maintained without prejudice to the pending tender. WAL's insurance broker should be instructed to review all renewal terms, amendments, and endorsements and to flag any provisions that could adversely affect WAL's rights with respect

1. Finalize Contingency Reactivation Plan. Calderwood & Harkness will finalize the contingency reactivation plan outlined in Patrick Gallagher's February 20, 2025 memorandum (Attachment C). The reactivation plan addresses anticipated discovery needs, expert witness requirements, potential for early dispositive motion on the non-WP-4 overruns, and estimated timeline from reactivation to trial readiness.

2. Expert Witness Identification and Vetting. Calderwood & Harkness will identify and begin preliminary vetting of expert witnesses in two categories: (a) a damages expert with experience in government contract cost analysis, CPIF contract structures, and defense industry cost accounting; and (b) a government-contracts accounting expert with experience in FAR cost principles, CAS compliance, and DCMA audit processes.

3. Draft Motion to Lift Stay. Calderwood & Harkness will prepare a draft motion to lift the stay, to be filed promptly after the COFD issues. The motion will argue that the basis for the stay (the pendency of the DCMA administrative review) has been resolved and that the case should be returned to the active docket for scheduling and case management. 4. discovery Plan and Document Review Protocol. Calderwood & Harkne

5. Early Dispositive Motion on Non-WP-4 Overruns. Calderwood & Harkness will assess the potential for an early motion for partial summary judgment on the non-WP-4 overruns ($1,909,142). This issue presents a discrete legal question that is amenable to summary adjudication and, if successful, would reduce WAL's exposure by nearly 13% and narrow the scope of the remaining dispute.

6. Refreshed Litigation Budget. Calderwood & Harkness will prepare a refreshed litigation budget for the post-reactivation phases of the case once the COFD issues and the scope of remaining disputes is known. The refreshed budget will include estimated costs for fact discovery, expert discovery, dispositive motions, pretrial preparation, and trial. D. Lender and Financial Reporting

1. Supplemental Notice to Ridgeline. Calderwood & Harkness will evaluate whether a supplemental notice to Ridgeline National Bank, N.A. (David Kreutz, SVP) is advisable upon issuance of the COFD or lifting of the stay. A supplemental notice may be prudent if the COFD materially changes the amount in controversy or the nature of the claims, and will ensure continued compliance with Section 6.07(b) of the Credit Agreem

2. ASC 450 Reassessment. Calderwood & Harkness will coordinate with Pinnacle Advisory Partners LLC (Thomas Brennan, CPA, Engagement Partner) on a reassessment of the ASC 450 probability classification once the COFD issues. If the COFD confirms or increases the WP-4 allocation, the probability assessment may need to be revised from "reasonably possible" to "probable," which would require WAL to record an accrual on it

3. Continuation of Current Financial Statement Treatment. Pending any material change in circumstances — including but not limited to the issuance of the COFD, a definitive insurance coverage determination, or a settlement — WAL should continue the current financial statement treatment (reasonably possible / footnote disclosure, no accrual), which is consistent with the advice of both Calderwood & Harkness and Pinnac

1. Strategy Call. We recommend scheduling a call with Marcus J. Whitmore (CEO), Elaine Whitmore (CFO), Gregory Poole (General Counsel), and Catherine Soo-Hyun Park (VP, Government Contracts) to discuss this memorandum, review the recommended next steps, and confirm strategic direction. Calderwood & Harkness is available to conduct this call at the client's convenience during the last two weeks of March 2025.

2. Quarterly Update. Calderwood & Harkness will provide its next quarterly status update to the client after the filing of the seventh joint status report, anticipated for approximately July 2025. Ad hoc updates will be provided as warranted by material developments, including any communication from DCMA regarding the COFD timeline or any response from Meridian regarding the coverage determination.

XII. Conclusion This matter remains dormant as a result of the stay entered by Judge Brannigan on March 17, 2023, but it requires continued active monitoring on multiple fronts. The four primary workstreams — the DCMA administrative review, insurance coverage, credit facility compliance, and financial reporting — each demand ongoing attention and coordination. The issuance of the COFD by ACO Lt. Col. Sandra M. Vicker